Key Segmentation
By Product
-
Devices
-
Defibrillators
-
Extracorporeal Membrane Oxygenation
-
Intra-Aortic Balloon Pump
-
Percutaneous VAD
-
Other Devices
-
-
Drugs
-
Anti-Arrhythmic Drugs
-
Vasopressors & Inotropes
-
By Distribution Channel
-
Hospitals
-
Retail Pharmacies
-
Online Pharmacies
-
Others
By End User
-
Hospitals & Cardiac Centres
-
Emergency Medical Services
-
Home & Alternate Care Settings
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Abbott Laboratories, Novartis AG, ZOLL Medical Corporation, Stryker Corporation, and GE HealthCare Technologies Inc., among others.
Key opportunities include connected, workflow-integrated resuscitation ecosystems, precision post-arrest temperature management, and expansion of home-based monitoring and wearable defibrillation technologies.
The primary growth factor is the rising global burden of sudden cardiac arrest among ageing populations, combined with expanding public-access defibrillator programs and device miniaturization.
By product, the Devices segment dominates the Cardiac Arrest Treatment Market with approximately 69.12% share in 2025.
North America dominates the Cardiac Arrest Treatment Market with approximately 41.83% share in 2025.
